tizanidine hydrochloride

Product NDC
0185-0034
11-digit product format
001850034
Labeler code
0185
Product ID
0185-0034_2773d3c8-40a1-4a53-b67a-097c910f3ae0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
tizanidine hydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
Eon Labs, Inc.
Application
ANDA076280
Marketing category
ANDA
Marketing start
2002-11-26
Marketing end
2022-09-30
Substance
TIZANIDINE HYDROCHLORIDE
Active strength
2 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a0ff02d8-b711-423c-b7d1-ada00d81c743Product name120250805
9fd28b3a-d1bb-a2ce-ffa3-c3dd28536a01Product name820250313
b404127e-1c01-47bb-874e-db1e0b6bd9afProduct name420250313

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0185-0034-10EA - Each0185-003405a96f71-1431-40c9-9043-29573c6bee3612012-07-24
0185-0034-51EA - Each0185-0034f0aca024-96b4-45ad-a507-cf176eced1e212012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
TIZANIDINE HYDROCHLORIDEACTIVE INGREDIENTB53E3NMY5CTIZANIDINE HYDROCHLORIDE TABLET [STAT RX USA LLC]3
TIZANIDINEACTIVE MOIETY6AI06C00GWTIZANIDINE HYDROCHLORIDE TABLET [STAT RX USA LLC]3
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UTIZANIDINE HYDROCHLORIDE TABLET [STAT RX USA LLC]3
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4TIZANIDINE HYDROCHLORIDE TABLET [STAT RX USA LLC]3
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XTIZANIDINE HYDROCHLORIDE TABLET [STAT RX USA LLC]3
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APTIZANIDINE HYDROCHLORIDE TABLET [STAT RX USA LLC]3

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
313412tiZANidine HCl 2 MG Oral TabletPSN43d51c1d-5f5b-4b9e-95d0-d12ceff8d84e3
313413tiZANidine HCl 4 MG Oral TabletPSN43d51c1d-5f5b-4b9e-95d0-d12ceff8d84e3
313412tizanidine 2 MG Oral TabletSCD43d51c1d-5f5b-4b9e-95d0-d12ceff8d84e3
313413tizanidine 4 MG Oral TabletSCD43d51c1d-5f5b-4b9e-95d0-d12ceff8d84e3
313412tizanidine 2 MG (as tizanidine HCl 2.288 MG) Oral TabletSY43d51c1d-5f5b-4b9e-95d0-d12ceff8d84e3
313413tizanidine 4 MG (as tizanidine HCl 4.576 MG) Oral TabletSY43d51c1d-5f5b-4b9e-95d0-d12ceff8d84e3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0185-0034-10001850034101000 TABLET in 1 BOTTLE (0185-0034-10) 1000 tablet2002-11-262021-05-31NoNoCurrent
0185-0034-5100185003451150 TABLET in 1 BOTTLE (0185-0034-51) 150 tablet2002-11-262022-03-31NoNoCurrent